Latham & Watkins Represents Underwriters in Alamar Biosciences’ Upsized US$191.3 Million Initial Public Offering

"Latham & Watkins represented the underwriters in Alamar Biosciences’ upsized IPO of 11,250,000 shares at US$17 per share, with a 30‑day option for 1,687,500 additional shares. Shares began trading on Nasdaq (ALMR) April 17, 2026. Gross proceeds are expected to be approximately US$191.3 million; closing is expected April 20, 2026."

Latham & Watkins LLP represented the underwriters in the initial public offering of Alamar Biosciences, Inc. Alamar Biosciences, Inc. priced an upsized initial public offering of 11,250,000 shares of its common stock at a public offering price of US$17 per share. In connection with the offering, Alamar granted the underwriters a 30‑day option to purchase up to an additional 1,687,500 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Select Market on April 17, 2026, under the ticker symbol ALMR. The gross proceeds from the offering are expected to be approximately US$191.3 million, without giving effect to the underwriters’ option to purchase additional shares and before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on April 20, 2026, subject to the satisfaction of customary closing conditions. Latham & Watkins LLP represented the underwriters in the offering with a Capital Markets team composed by: New York partner Nathan Ajiashvili (Capital Markets); Orange County/Bay Area partner Ross McAloon (Capital Markets); and associates Raul Gonzalez Cassarubias, Lexi Zintel, and Skyler Ligon (Capital Markets).

Menu

Latham & Watkins Represents Underwriters in Alamar Biosciences’ Upsized US$191.3 Million Initial Public Offering

Read the full story

Menu

Latham & Watkins Represents Underwriters in Alamar Biosciences’ Upsized US$191.3 Million Initial Public Offering

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads